Log in

NYSE:CCM - Concord Medical Services Stock Price, Forecast & News

$2.71
+0.01 (+0.37 %)
(As of 12/5/2019 09:25 AM ET)
Today's Range
$2.69
Now: $2.71
$2.71
50-Day Range
$2.24
MA: $2.60
$2.87
52-Week Range
$1.85
Now: $2.71
$3.82
Volume2,182 shs
Average Volume7,165 shs
Market Capitalization$117.36 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.2
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company's services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, CyberKnife robotic radiosurgery system, proton beam therapy systems, and diagnostic imaging services. Read More…

Industry, Sector and Symbol

Industry Offices & clinics of medical doctors
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone86-10-5903-6688

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$27.76 million
Book Value$1.86 per share

Profitability

Miscellaneous

Employees583
Market Cap$117.36 million
Next Earnings DateN/A
OptionableNot Optionable

Receive CCM News and Ratings via Email

Sign-up to receive the latest news and ratings for CCM and its competitors with MarketBeat's FREE daily newsletter.


Concord Medical Services (NYSE:CCM) Frequently Asked Questions

What is Concord Medical Services' stock symbol?

Concord Medical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "CCM."

How were Concord Medical Services' earnings last quarter?

Concord Medical Services Hldg Ltd (NYSE:CCM) announced its earnings results on Wednesday, August, 24th. The company reported ($0.06) earnings per share for the quarter, missing analysts' consensus estimates of $0.21 by $0.27. The firm had revenue of $18.93 million for the quarter. View Concord Medical Services' Earnings History.

Has Concord Medical Services been receiving favorable news coverage?

News articles about CCM stock have been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Concord Medical Services earned a news sentiment score of 0.9 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Concord Medical Services.

Are investors shorting Concord Medical Services?

Concord Medical Services saw a decrease in short interest during the month of November. As of November 15th, there was short interest totalling 2,700 shares, a decrease of 20.6% from the October 31st total of 3,400 shares. Based on an average daily volume of 3,000 shares, the short-interest ratio is presently 0.9 days. Approximately 0.0% of the shares of the stock are sold short. View Concord Medical Services' Current Options Chain.

Who are some of Concord Medical Services' key competitors?

What other stocks do shareholders of Concord Medical Services own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Concord Medical Services investors own include Hi-Crush Partners (HCLP), The Carlyle Group (CG), Fibrocell Science (FCSC), Laurentian Bank of Canada (LB), Biocept (BIOC), Corcept Therapeutics (CORT), DURECT (DRRX), China Nepstar Chain Drugstore (NPD), CEL-SCI (CVM) and NovaBay Pharmaceuticals (NBY).

Who are Concord Medical Services' key executives?

Concord Medical Services' management team includes the folowing people:
  • Dr. Jianyu Yang, Chairman & CEO (Age 48)
  • Mr. Yaw Kong Yap, CFO & Pres (Age 55)
  • Ms. Xiao Fu, Chief Operating Officer (Age 52)
  • Dr. Matthew D. Callister, Chief Medical Officer (Age 49)
  • Ms. Xun Liu, Financial Controller

Who are Concord Medical Services' major shareholders?

Concord Medical Services' stock is owned by a number of of institutional and retail investors. Top institutional investors include Wedbush Securities Inc. (0.02%).

Which institutional investors are selling Concord Medical Services stock?

CCM stock was sold by a variety of institutional investors in the last quarter, including Wedbush Securities Inc..

How do I buy shares of Concord Medical Services?

Shares of CCM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Concord Medical Services' stock price today?

One share of CCM stock can currently be purchased for approximately $2.71.

How big of a company is Concord Medical Services?

Concord Medical Services has a market capitalization of $117.36 million and generates $27.76 million in revenue each year. The company earns $-34,160,000.00 in net income (profit) each year or ($1.20) on an earnings per share basis. Concord Medical Services employs 583 workers across the globe.View Additional Information About Concord Medical Services.

What is Concord Medical Services' official website?

The official website for Concord Medical Services is http://www.concordmedical.com/.

How can I contact Concord Medical Services?

Concord Medical Services' mailing address is 18/F TOWER A GLOBAL TRADE CENTER 36 NORTH THIRD RING ROAD, BEIJING F4, 100013. The company can be reached via phone at 86-10-5903-6688 or via email at [email protected]


MarketBeat Community Rating for Concord Medical Services (NYSE CCM)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  181 (Vote Outperform)
Underperform Votes:  189 (Vote Underperform)
Total Votes:  370
MarketBeat's community ratings are surveys of what our community members think about Concord Medical Services and other stocks. Vote "Outperform" if you believe CCM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CCM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/5/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel